Description of Athru-Derm 1% Lotion 50g (1g/100g)
Athru-Derm: Fast relief from Arthritis pain and muscle injuries:
Topical non-steroidal analgesic and anti-infammatory cream with Diclofenac-sodium 1g/100g (1%) as active ingredient. Unlike other Diclofenac-sodium lotions, ours features MZL Emzaloid® Technology, which enables the active ingredient to penetrate the skin efficiently. Therefore, quicker and better results!
The Science and Emzaloid® Technology behind Athru-Derm lotion offer:
Diclofenac encapsulated in a unique and patented theurapeutic system, which ensures effective absorption into the skin.
Unique lotion formulation that allows for easy application.
Leaves no sticky residue on the skin.
No intrusive smell.
Apply 3 to 4 times per day on affected area.
Available in 50g for acute application.
Athru-Derm Lotion is indicated for the symptomatic relief of localised traumatic inflammation and pain.
Athru-Derm Lotion has anti-inflammatory and analgesic properties.
A smooth white milky lotion.
Athru-Derm Lotion contains:
Diclofenac Sodium 1,08 g equivalent to Diclofenac 1g per 100g (1%)
Imidurea 0,25% m/m
Sodium propylparaben 0,25% m/m
Methylparaben. 0,22% m/m
Butylated Hydroxyanisole 0,0075% m/m
Butylated Hydroxytoluene 0,0225% m/m
Hypersensitivity to Diclofenac, aspirin and other non-steroidal anti-inflammatory medicines. Diffuse skin diseases, burns and ulcers. Athru-Derm Lotion should not be used by patients with porphyria.
Confine use to adults as safety and efficacy have not been established in children. The safety of Athru-Derm Lotion in pregnancy has not been established.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Itching, reddening, or smarting of the skin or outbreak of a rash may occur.
When Athru-Derm Lotion is applied to relatively large areas of skin and over a prolonged period, the possibility of systemic side-effects cannot be completely excluded.
Side-effects as experienced with systemically absorbed Diclofenac Sodium include the following: gastro-intestinal disturbances such as nausea and vomiting, gastro-intestinal bleeding or activation of peptic ulcer, headache, slight dizziness, nervousness, tinnitus, depression, drowsiness and insomnia. Hypersensitivity reactions such as fever and rashes; hepatotoxicity, aseptic meningitis, bronchospasm in patients with asthma, cystitis, haematuria, acute renal failure, interstitial nephritis and nephrotic syndrome, Other side-effects experienced after oral administration are anaemias, thrombocytopenia, eosinophilia, agranulocytosis, abnormalities in liver function tests, blurred vision, changes in visual colour perception and toxic amblyopia.
Athru-Derm Lotion should be applied to intact skin surfaces, and not to skin wounds or open injuries. It should not be allowed to come into contact with the eyes or with mucous membranes.
Not to be taken by mouth.
Interactions as experienced with systemically absorbed Diclofenac sodium:
When given concomitantly with Lithium, Digoxin or Methotrexate, Diclofenac Sodium raises their concentrations in the blood.
The bioavailability of Athru-Derm Lotion is reduced by aspirin and that of aspirin by Athru-Derm Lotion, when the two medicines are administered together.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
In the event of significant systemic side-effects occurring as a result of improper use or accidental overdosage, general therapeutic measures of the kind normally adopted in order to treat poisoning with non-steroidal anti-inflammatory medicines should be applied.
DOSAGE AND DIRECTIONS FOR USE:
Apply Athru-Derm Lotion to intact skin three to four times daily.
Store below 25°C protect from light. Keep well closed.
KEEP OUT OF REACH OF CHILDREN.
Products Similar to Athru-Derm 1% Lotion 50g (1g/100g)
LINOTAR PSE Moisturizing Cream
LINOTAR leave on Scalp Conditioner
LINOTAR Skin Combinaton 3-Pack
COVAREX: 3 MZL anti-fungal Creams
EXOREX Gel 1% & 2% - Discontinued!